- French biotech Pharnext ( OTC:PNEXF ) appointed Rob Quinn as CFO, effective immediately.
- Quinn replaces Valérie Worrall, who stepped down to pursue other interests, the company said in a Sept. 1 press release.
- Quinn recently served as CFO of BenevolentAI, a Euronext-listed AI-driven drug discovery company and previously served as CFO at Silence Therapeutics.
- Pharnext noted that Quinn will be responsible for investor relations, advancing new fundraising opportunities and supporting long term growth plans.
For further details see:
Pharnext appoints former Silence Therapeutics exec as CFO